"Our participation in spine conferences around the world reflects our belief in partnering with the most influential societies, study groups and congresses to advance spine care and change patient lives," said
- 52nd Annual Meeting of the
Japanese Society for Spinal Surgery and Related Research(JSSR): April 13–15 in Sapporo, Japan, NuVasivewill celebrate XLIF and showcase the X360 portfolio.
- BritSpine 2023: April 18–20 in
Scotland, United Kingdom, NuVasivewill feature the X360 and Complex portfolios enabled by Pulse at booth #1.
- 2023 American Association of Neurological Surgeons (AANS) Annual
Scientific Meeting: April 21–23 in Los Angeles, NuVasivewill celebrate XLIF, feature all 360 portfolios and highlight the Spine Precision Partnershipwith Siemens Healthineers at booth #1147.
Pediatric Orthopaedic Society of North America(POSNA) Annual Meeting: April 26–28 in Nashville, NuVasivewill feature its magnetically adjustable implant systems, Precice and MAGEC at booth #603/703.
- SpineWeek 2023: May 1–5 in
Melbourne, Australia, NuVasivewill celebrate XLIF and feature X360, C360and Complex portfolios enabled by Pulse at booth #C2.
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons and hospitals, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products, the Company's ability to adequately manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nuvasive-to-participate-in-upcoming-global-spine-conferences-301793872.html
Investor, Juliet C. Cunningham, NuVasive, Inc., 858-210-2129, email@example.com; Media: Melanie Ordoñez, NuVasive, Inc., 858-722-3899, firstname.lastname@example.org